Almost eight in 10 patients (79%) say they prefer prescription cannabis medicines to illicit cannabis (21%), according to new research from the Cannabis Industry Council (CIC). Patients were also asked whether they preferred prescription or illicit cannabis based upon a range of factors, including cost, quality, product range, reliability of supply, medical effectiveness, fear of […]
Read More
The NHS is failing to prescribe cannabis flower medication to any patients, including those with conditions such as epilepsy, chronic pain, and cancer, according to new research from the Cannabis Industry Council (CIC). The CIC asked 152 NHS Foundation Trusts in England how many individuals they had prescribed cannabis flos (flower) to between 2019 and […]
Read More
Allowing medical cannabis to be prescribed on the NHS for chronic pain could save the state healthcare provider almost £4 billion annually, according to a new research study. The research found that when a patient was prescribed medical cannabis for chronic pain, instead of alternative treatments, this saved the NHS £729 each year, as well […]
Read More
A good practice guide for prescription cannabis clinics has been published by the Cannabis Industry Council (CIC). The guidance includes 10 principles of good practice, as well as five specific policies for clinics to implement. The aim of the good practice guide is to encourage ethical and responsible operations, build industry collaboration, and deliver improved […]
Read More
The “number of items for private prescribing of unlicensed cannabis-based medicines” increased from 6,137 in September 2021 to 22,431 in September 2023. That’s according to an NHS Business Services Authority response to a freedom of information request. Business of Cannabis report that this equates to an compound annual growth rate of 83%. However, the UK […]
Read More
The Cannabis Industry Council (CIC) is pleased to announce three new additions to our Executive Committee, as follows: Standards Working Group Chair – Frances Crewdson (CannDo Consulting) Prescription Working Group Co-Chair – Sonal Patel (Aurora) Supply Chain Representative – James Leavesley (Dalgety) A very warm welcome to Frances, Sonal and James. We look forward to […]
Read More
The CIC has written to the Advisory Council on the Misuse of Drugs (ACMD) calling on them to back raising the THC permissable in hemp crops. The Government previously asked the ACMD to advise them on potentially increasing the limit to “at least 0.3%”. The CIC has also urged the ACMD to support a reduction […]
Read More
Landlords, property managers, and housing associations are currently at risk of breaching the Equality Act over their approach to prescription cannabis, according to a new Cannabis Industry Council (CIC) report. Entitled ‘The Use of Prescription Cannabis in Buildings’, the report reminds housing providers of their obligations under the Equality Act 2010, which prohibits discrimination based […]
Read More
Voting is open for the inaugural Cannabis Industry Awards, with two individual awards set to be handed out later this year. The two individual outstanding achievement awards are for Social Impact and Contribution to Science. The shortlist is as follows: Contribution to Science Award (sponsored by Gowling WLG) Alkyoni Athanasiou-Fragkouli and Prof. Michael Lynskey (Drug […]
Read More
The CIC and Drug Science have written to new Drugs Minister Dame Diana Johnson MP, calling for a liberalisation of the regulations around research. We are calling on the Government to back a number of recommendations they have received from the Advisory Council on the Misuse of Drugs (ACMD). Implementing these recommendations will reduce licencing […]
Read More